Stockreport

Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF Announced agreement with Roche to support advancement of amezalpat into first-line HCC pivotal Phase 3 trial Received final funding approval from NCI to move TPST-149 [Read more]